Long-term follow-up of diabetic and non-diabetic patients with chronic hepatitis C successfully treated with direct-acting antiviral agents.
Alessia CiancioDavide Giuseppe RibaldoneAnna DottaChiara GiordaninoMarco SaccoSharmila FagooneeRinaldo PellicanoGiorgio Maria SaraccoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
SVR achieved by DAAs is associated with long-term improvement of glycometabolic control in diabetic patients, but among cirrhotics DM still exerts a detrimental effect on the liver.